PM HeartIHD prediction: The calculated prediction and the explainability factors will be made available to the physician, which the physician then can decide to take into his/hers evaluation about further treatment.
Study summary
The PM-Heart algorithm (PMHeartIHD) is an in-house developed software that predict the survival prognosis for the individual patient hospitalized with ischemic heart disease (IHD) after a coronary arteriography has been performed. The software is intended to be used as a clinical decision support system i.e. the calculated survival prognosis is expected to enhance the quality of the treating physician's therapeutic considerations concerning (minor) adjustments to the patients treatment and follow-up - all within the framework of the current medical guidelines. Thus, the algorithm does not "show the physician specifically what to do", but rather ensures a better knowledgebase for the overall interpretation and choice of management of the patient.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Hospitalized patients in one of the involved departments of cardiology (see below) with;
* Ischemic heart disease; the clinical presentation may be stable, worsening/unstable angina, non-ST-elevation myocardial infarction or ST-elevation myocardial infarction, and with - Significant coronary artery lesions or diffuse coronary artery disease on invasive coronary angiography during the admission
Exclusion Criteria:
* \<18 years of age
* Living outside Denmark
Primary outcome measure(s)
Number and duration of readmissions within one month after randomization — From randomization to the study and up to 1 year hereafter A composite outcome of a) readmissions within one month, and 2) all-cause mortality within one year - for patients randomized to the study.
All the outcomes listed below will be assessed as a comparison between the "intervention group" and the "control group".
Number and cause of death (all-cause mortality) within one year after randomization — From randomization to the study and up to 1 year hereafter A composite outcome of a) readmissions within one month, and 2) all-cause mortality within one year - for patients randomized to the study.
Trial sites (1)
Facility
City
Region
Status
Department of Cardiology, The Heart Centre, Rigshospitalet Copenhagen University Hospital.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.